Jonosteril D 5

Magnesium Chloride Hexahydrate, the active ingredient in Jonosteril D 5, is an electrolyte solution presented as an intravenous solution for intravenous use. It provides essential electrolytes and glucose to support fluid resuscitation and correct electrolyte imbalances in patients requiring intravenous therapy.

GNH USA supplies Jonosteril D 5 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Jonosteril D 5 is an intravenous electrolyte solution used in clinical situations that require rapid restoration of fluid and electrolyte balance. - Electrolyte replacement: restores sodium, potassium, calcium, magnesium and glucose levels in patients with depleted electrolytes. - Fluid resuscitation: expands intravascular volume in hypovolemic patients. - Correction of electrolyte imbalances: adjusts specific ion concentrations during surgery or critical illness. - Perioperative management: maintains electrolyte homeostasis during major surgical procedures.

Jonosteril D 5 may be associated with a range of infusion‑related reactions.

Common Side Effects: - Phlebitis at the infusion site: mild inflammation of the vein. - Mild hypernatremia: transient elevation of serum sodium. - Transient hyperkalemia: temporary increase in potassium levels. - Nausea: occasional feeling of queasiness during infusion.

Serious or Rare Side Effects: - Severe hypermagnesemia: can cause respiratory depression and cardiac arrest. - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte shifts. - Severe electrolyte imbalance: profound disturbances requiring immediate medical intervention.

When using Jonosteril D 5, clinicians should observe specific safety measures. - Renal impairment: monitor electrolyte levels closely and adjust infusion rate. - Cardiac disease: assess baseline potassium and magnesium before administration. - Hypervolemia: avoid in patients with fluid overload or congestive heart failure. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Drug compatibility: verify compatibility with other intravenous solutions before mixing. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Jonosteril D 5 can interact with several medications that affect electrolyte balance.

Major Interactions (Avoid): - Calcium gluconate: may precipitate when mixed, leading to catheter blockage. - Potassium‑sparing diuretics: increase risk of hyperkalemia. - Magnesium‑containing antacids: excess magnesium can cause toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor serum potassium for possible elevation. - Beta‑blockers: watch for bradycardia when electrolyte shifts occur. - Loop diuretics: may require adjustment of electrolyte replacement dosing.